Genetic Background of Macular Telangiectasia Type 2

Area of Science:

• Ophthalmology
• Genetics
• Metabolic Disorders

Background:

• Macular telangiectasia type 2 (MacTel) is a progressive macular disease often diagnosed late.
• Earlier detection is now possible due to advances in diagnostic techniques.
• MacTel is genetically complex, with multiple risk-contributing variants.

Purpose of the Study:

• To review and summarize genetic findings related to MacTel.
• To explore the potential of MacTel as an inherited retinal disorder.

Main Methods:

• Literature review of clinical reports and publications on MacTel genetics.
• Analysis of genetic factors implicated in amino acid, lipid, and urea cycle metabolism.
• Investigation of variants in genes related to retinal vasculature and sphingolipid metabolism.

Main Results:

• Disease-associated variants identified in genes involved in glycine/serine metabolism, urea cycle, and lipid metabolism.
• Variants in sphingolipid and fatty acid/steroid/retinol metabolism genes found in patients with neurological comorbidities.
• Genetic alterations disrupt retinal metabolic pathways, leading to cell degradation and vision loss.

Conclusions:

• Genetic factors play a significant role in MacTel pathogenesis.
• Further investigation into MacTel as an inherited retinal disorder is warranted based on identified genetic links.
• Understanding these genetic pathways may lead to earlier diagnosis and targeted therapies.